Effectiveness of human mesenchymal stem cells derived from bone marrow cryopreserved for 23-25 years

Cryobiology

Volumn 64, Issue 3, 2012, Pages 167-175

  Shen, Jian Liang ^a   Huang, You Zhang ^a   Xu, Shi Xia ^a   Zheng, Pei Hao ^a   Yin, Wen Jie ^a   Cen, Jian ^a   Gong, Li Zhong ^a  

^a NAVY GENERAL HOSPITAL   (China)

Author keywords

BMCs; Cryopreservation; In vitro differentiation; Mesenchymal stem cells

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BETA1 INTEGRIN; CD34 ANTIGEN; CD45 ANTIGEN; CD71 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; HLA DR ANTIGEN; THY 1 ANTIGEN;

ADIPOCYTE; ARTICLE; BONE MARROW CULTURE; CELL ADHESION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CRYOPRESERVATION; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; NERVE CELL DIFFERENTIATION; OSTEOBLAST; PRIORITY JOURNAL;

ADIPOCYTES; ANTIGENS, CD; BIOLOGICAL SPECIMEN BANKS; BONE MARROW CELLS; CELL ADHESION; CELL COUNT; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELLS; NEURONS; OSTEOBLASTS; TIME FACTORS;

EID: 84862782262     PISSN: 00112240     EISSN: 10902392     Source Type: Journal    
DOI: 10.1016/j.cryobiol.2012.01.004     Document Type: Article

References (45)

1. Alessio N., Squillaro T., Cipollaro M., Bagella L., Giordano A., Galderisi U. The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways. Oncogene 2010, 29:5452-5463.
2. Boos A.M., Loew J.S., Deschler G., Arkudas A., Bleiziffer O., Gulle H., Dragu A., Kneser U., Horch R.E., Beier J.P. Directly auto-transplanted mesenchymal stem cells induce bone formation in a ceramic bone substitute in an ectopic sheep model. J. Cell. Mol. Med. 2011, 15:1364-1378.
3. Brandl A., Meyer M., Bechmann V., Nerlich M., Angele P. Oxidative stress induces senescence in human mesenchymal stem cells. Exp. Cell. Res. 2011, 31:1541-1547.
4. Broxmeyer H.E., Cooper S. High-efficiency recovery of immature haematopoietic progenitor cells with extensive proliferative capacity from human cord blood cryopreserved for 10years. Clin. Exp. Immunol. 1997, 107(Suppl. 1):45-53.
5. Carvalho K.A., Cury C.C., Oliveira L., Cattaned R.I., Malvezzi M., Francisco J.C., Pachalok A., Olandoski M., Faria-Neto J.R., Guarita-Souza L.C. Evaluation of bone marrow mesenchymal stem cell standard cryopreservation procedure efficiency. Transplant. Proc. 2008, 40:839-841.
6. Casado-Diaz R., Santiago-Mora R., Jimenez J., Caballero-Villarraso C., Herrera A., Torres G., Dorado J.M., Quesada-Gomez Cryopreserved human bone marrow mononuclear cells as a source of mesenchymal stromal cells: application in osteoporosis research. Cytotherapy 2008, 10:460-468.
7. Chin S.P., Poey A.C., Wong C.Y., Chang S.K., Teh W., Mohr T.J., Cheong S.K. Cryopreserved mesenchymal stromal cell treatment is safe and feasible for severe dilated ischemic cardiomyopathy. Cytotherapy 2010, 12:31-37.
8. da Silva Meirelles L., Caplan A.I., Nardi N.B. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008, 26:2287-2299.
9. da Silva Meirelles L., Chagastelles P.C., Nardi N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell. Sci. 2006, 119:2204-2213.
10. Dvorakova J., Hruba A., Velebny V., Kubala L. Isolation and characterization of mesenchymal stem cell population entrapped in bone marrow collection sets. Cell. Biol. Int. 2008, 32:1116-1125.
11. Grein T.A., Freimark D., Weber C., Hudel K., Wallrapp C., Czermak P. Alternatives to dimethylsulfoxide for serum-free cryopreservation of human mesenchymal stem cells. Int. J. Artif. Organs 2010, 33:370-380.
12. Huang Y.Z., Wang S.H., Yang P.D., Xiang D., Shen J.L., Zuo J., Tang Y.H. Biological properties of long-term cryopreserved human BMCs. Chinese J. Appl. Physiol. 2001, 17:359-382.
13. Ishimura T., Yamamoto N., Tajima K., Ohno A., Yamamoto Y., Washimi O., Yamada H. Differentiation of adipose-derived stromal vascular fraction culture cells into chondrocytes using the method of cell sorting with a mesenchymal stem cell marker. Tohoku J. Exp. Med. 2008, 216:149-156.
14. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Largaespada D.A., Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
15. Katayama Y., Yano T., Bessho A., Deguchi S., Sunami K., Mahmut N., Shinagawa K., Omoto E., Makino S., Miyamoto T., Mizuno S., Fukuda T., Eto T., Fujisaki T., Ohno Y., Inaba S., Niho Y., Harada M. The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells. Bone Marrow Transplant. 1997, 19:283-287.
16. Kemp K.C., Hows J., Donaldson C. Bone marrow-derived mesenchymal stem cells. Leuk. Lymphoma 2005, 46:1531-1544.
17. Kobylka P., Ivanyi P., Breur-Vriesendorp B.S. Preservation of immunological and colony-forming capacities of long-term (15years) cryopreserved cord blood cells. Transplantation 1998, 65:1275-1278.
18. Kotobuki N., Hirose M., Machida H., Katou Y., Muraki K., Takakura Y., Ohgushi H. Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells. Tissue Eng. 2005, 11:663-673.
19. Kuo C.K., Tuan R.S. Tissue engineering with mesenchymal stem cells. IEEE Eng. Med. Biol. Mag. 2003, 22:51-56.
20. Li H., Fan X., Kovi R.C., Jo Y., Moquin B., Konz R., Stoicov C., Kurt-Jones E., Grossman S.R., Lyle S., Rogers A.B., Montrose M., Houghton J. Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res. 2007, 67:10889-10898.
21. Liu G., Shu C., Cui L., Liu W., Cao Y. Tissue-engineered bone formation with cryopreserved human bone marrow mesenchymal stem cells. Cryobiology 2008, 56:209-215.
22. Liu Y., Xu X., Ma X., Martin-Rendon E., Watt S., Cui Z. Cryopreservation of human bone marrow-derived mesenchymal stem cells with reduced dimethylsulfoxide and well-defined freezing solutions. Biotechnol. Prog. 2010, 26:1635-1643.
23. Luo K., Wu G., Wang Q., Sun Y., Liu H. Effect of dimethylsulfoxide and hydroxyethyl starch in the preservation of fractionated human marrow cells. Cryobiology 1994, 31:349-354.
24. Makino S., Harada M., Akashi K., Taniguchi S., Shibuya T., Inaba S., Niho Y. A simplified method for cryopreservation of peripheral blood stem cells at -80 degrees C without rate-controlled freezing. Bone Marrow Transplant. 1991, 8:239-244.
25. Markov V., Kusumi K., Tadesse M.G., William D.A., Hall D.M., Lounev V., Carlton A., Leonard J., Cohen R.I., Rappaport E.F., Saitta B. Identification of cord blood-derived mesenchymal stem/stromal cell populations with distinct growth kinetics, differentiation potentials, and gene expression profiles. Stem Cells Dev. 2007, 16:53-73.
26. McCullough J., Haley R., Clay M., Hubel A., Lindgren B., Moroff G. Long-term storage of peripheral blood stem cells frozen and stored with a conventional liquid nitrogen technique compared with cells frozen and stored in a mechanical freezer. Transfusion 2010, 50:808-819.
27. Montanari M., Capelli D., Poloni A., Massidda D., Brunori M., Spitaleri L., Offidani M., Lucesole M., Masia M.C., Balducci F., Refe C., Piani M., Leoni P., Olivieri A. Long-term hematologic reconstitution after autologous peripheral blood progenitor cell transplantation: a comparison between controlled-rate freezing and uncontrolled-rate freezing at 80 degrees C. Transfusion 2003, 43:42-49.
28. Motta J.P., Gomes B.E., Bouzas L.F., Paraguassu-Braga F.H., Porto L.C. Evaluations of bioantioxidants in cryopreservation of umbilical cord blood using natural cryoprotectants and low concentrations of dimethylsulfoxide. Cryobiology 2010, 60:301-307.
29. Prasad V.K., Lucas K.G., Kleiner G.I., Talano J.A., Jacobsohn D., Broadwater G., Monroy R., Kurtzberg J. Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. Biol. Blood Marrow Transplant. 2011, 17:534-541.
30. Phuc P.V., Nhung T.H., Loan D.T., Chung D.C., Ngoc P.K. Differentiating of banked human umbilical cord blood-derived mesenchymal stem cells into insulin-secreting cells. In Vitro Cell. Dev. Biol. Anim. 2011, 47:54-63.
31. Shin M., Yoshimoto H., Vacanti J.P. In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng. 2004, 10:33-41.
32. Spurr E.E., Wiggins N.E., Marsden K.A., Lowenthal R.M., Ragg S.J. Cryopreserved human haematopoietic stem cells retain engraftment potential after extended (5-14years) cryostorage. Cryobiology 2002, 44:210-217.
33. Stiff P.J., Koester A.R., Weidner M.K., Dvorak K., Fisher R.I. Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethyl starch without controlled-rate freezing. Blood 1987, 70:974-978.
34. Stiff P.J., Murgo A.J., Zaroulis C.G., DeRisi M.F., Clarkson B.D. Unfractionated human marrow cell cryopreservation using dimethylsulfoxide and hydroxyethyl starch. Cryobiology 1983, 20:17-24.
35. Sun H.J., Bahk Y.Y., Choi Y.R., Shim J.H., Han S.H., Lee J.W. A proteomic analysis during serial subculture and osteogenic differentiation of human mesenchymal stem cell. J. Orthop. Res. 2006, 24:2059-2071.
36. Svinareva D.A., Shipunova I.N., Ol'shanskaia Iu V., Momotiuk K.S., Drize N.I., Savchenko V.G. The basic properties of mesenchymal stromal cells from the donor bone marrow: superficial markers. Ter. Arkh. 2010, 82:52-56.
37. Tateishi-Yuyama E., Matsubara H., Murohara T., Ikeda U., Shintani S., Masaki H., Amano K., Kishimoto Y., Yoshimoto K., Akashi H., Shimada K., Iwasaka T., Imaizumi T. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002, 360:427-435.
38. Tokumoto S., Sotome S., Torigoe I., Omura K., Shinomiya K. Effects of cryopreservation on bone marrow derived mesenchymal cells of a nonhuman primate. J. Med. Dent. Sci. 2008, 55:137-143.
39. Trivedi P., Tray N., Nguyen T., Nigam N., Gallicano G.I. Mesenchymal stem cell therapy for treatment of cardiovascular disease: helping people sooner or later. Stem Cells Dev. 2010, 19:1109-1120.
40. Wang S.Y., Ho C.K., Chen P.M., Yung C.H., Chong L.L., Chen L.Y. Comparison of stem cell viability of bone marrow cryopreserved by two different methods. Cryobiology 1987, 24:229-237.
41. Xiang Y., Zheng Q., Jia B., Huang G., Xie C., Pan J., Wang J. Ex vivo expansion, adipogenesis and neurogenesis of cryopreserved human bone marrow mesenchymal stem cells. Cell Biol. Int. 2007, 31:444-450.
42. Xue D., Zheng Q., Zong C., Li Q., Li H., Qian S., Zhang B., Yu L., Pan Z. Osteochondral repair using porous poly(lactide-co-glycolide)/nano-hydroxyapatite hybrid scaffolds with undifferentiated mesenchymal stem cells in a rat model. J. Biomed. Mater. Res. A 2010, 94:259-270.
43. Yang F., Yang N.L. Comparison between two isolation metheds of human mesenchymal stem cells in vitro. J. Clin. Rehabilitative Tissue Eng. Res. 2008, 12:473-476.
44. Zhao Z.G., Tang X.Q., Li W.M., You Y., Zou P. Biological characteristics and ability of supporting hematopoiesis of bone marrow mesenchymal stem cells pre- and post-cryop-reservation. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006, 14:304-307.
45. Chin S.P., Poey A.C., Wong C.Y., Chang S.K., Teh W., Mohr T.J., Cheong S.K. Cryopreserved mesenchymal stromal cell treatment is safe and feasible for severe dilated ischemic cardiomyopathy. Cytotherapy 2010, 12(1):31-37.